Glossary A-H
A
A
- AbilityNet
- ABN
- Action MS
- ACTH
- ACTRIMS
- Acupuncture
- Advocacy
- Aetiology
- Aimspro
- Alemtuzumab
- Alprostadil
- Altered sensations
- Alternative therapies
- Amalgam
- Amantadine
- Americas Committee for Treatment and Research in Multiple Sclerosis
- Amiloride
- Amitriptyline
- Ampyra
- Anaesthesia
- Antegren
- Antibodies
- Antiphospholipid syndrome
- Anxiety
- Aphasia
- Apitherapy
- APS
- Aricept
- Aromatherapy
- Aspartame
- Association of British Neurologists (ABN)
- Ataxia
- Atorvastatin
- Attention span
- ATX-MS-1467
- Aubagio
- Autoimmunity
- Avonex
- Axon
- Azathioprine
- Back pain
- Baclofen
- Baclofen pump
- Balance
- Banding
- Barber's chair syndrome
- Bedsores
- Bee venom therapy
- Benefits and tax credits
- Benign MS
- Beta interferon
- Beta interferon 1a (Avonex)
- Beta interferon 1a (Rebif)
- Beta interferon 1b (Betaferon)
- Beta interferon 1b (Extavia)
- Betaferon
- BG12
- Bladder and Bowel Foundation
- Bladder symptoms
- Blood-brain barrier
- Blood donation
- Bone marrow donation
- Botox
- Botulinum toxin
- Bowel symptoms
- Breastfeeding
- Burning sensations
- Campath
- Cannabis
- Car insurance
- Carbamazepine
- Care and Repair
- Care homes
- Carers
- Cari Loder regime
- Catheters
- Causes of MS
- Caverject
- CBT
- CCG
- CCSVI
- Central nervous system (CNS)
- Cerebrospinal fluid (CSF)
- Chemotherapy
- Children with MS
- Children with MS in their family
- Chinese medicine
- Chronic cerebro-spinal venous insufficiency (CCSVI)
- Chronic progressive MS
- Cialis
- CIS
- Citizens Advice
- Civil Legal Service
- Cladribine
- Clinical Commissioning Groups
- Clinical psychologist
- Clinical trial
- Clinically isolated syndrome
- Clonazepam
- Clonus
- CNS
- Cobra venom
- Cochrane reviews
- Cognition and cognitive symptoms
- Cognitive behavioural therapy
- Commissioning Pathway
- Complementary and alternative medicine
- Concentration
- Constipation
- Continence
- Continence services
- Contraception
- Coordination
- Copaxone
- Copolymer-1
- Corticosteroids
- Counselling
- Crawling sensations
- Crying
- CSF
- CUPID
- Cure for MS
- Cyclophosphamide
- Cystitis
- Cystrin
- Daclizumab
- Dalfampridine
- Dantrium
- Dantrolene sodium
- DDA
- DDAVP Nasal
- Decubitus ulcers
- Deep brain stimulation
- Dental amalgam
- Depression
- Desmopressin
- Desmospray
- Desmotabs
- Demyelination
- Detrusitol
- Diagnosis
- DIAL Network
- Diazepam
- Diet
- Dietitian
- Differential diagnosis
- Dimethyl fumarate
- Dirucotide (MBP8298)
- Direct payments
- Directgov
- Disability Discrimination Act (DDA)
- Disability Law Service
- Disability, Pregnancy and Parenthood international
- Disability Rights UK
- Disabled Living Centres
- Disabled Living Foundation
- Disease modifying treatments
- Ditropan
- Dizziness
- Donepezil
- Double vision
- Doxycycline
- Driving
- Dropped foot
- Drugs and treatments used in the management of MS
- Dysaesthesia
- Dysarthria
- Dysphagia
- Dysphasia
- Dysport
- EBV
- Echinacea
- ECTRIMS
- EDSS
- Eliprodil
- Emotional lability
- Emotionalism
- Employment
- End stage MS
- Endoxana
- Epanutin
- Epidemiology
- Epstein Barr virus
- Equality Act
- Equipment
- Erectile dysfunction
- Esperanza homeopathic neuropeptide
- Estriol
- Estrogen
- Etiology
- European Committee for Treatment and Research In Multiple Sclerosis
- Evening primrose oil
- Evoked potentials
- Exemption from prescription charges
- Exercise
- Exhaustion
- Expanded Disability Status Scale
- Expert Patients Programme
- Extavia
- Eye problems